Skip to main content
Free research Free research Free assay review with research home and workspace preview
Quick search ChEMBL 36
Assay Detail

CHEMBL4618858

Review assay metadata, readout intent, target linkage, and publication context from the same page.

Binding
Inhibition of Human respiratory syncytial virus A2 Fusion protein expressed in Hep2 cells assessed as reduction in virus-induced cytopathic effect after 4 days by Celltiter-Glo viability assay
1
Total Activities
1
Compounds Tested
1
Activity Types
0
Assay Parameters

Assay Information

Assay Type Binding
Organism Human respiratory syncytial virus A2
Cell Type HEp-2
Confidence 8 — Homologous single protein target
Curated By Autocuration

Target

Fusion glycoprotein F0 (CHEMBL2364165)
Type SINGLE PROTEIN
Organism Human respiratory syncytial virus

Publication

Discovery of a Potent Dual Inhibitor of Wild-Type and Mutant Respiratory Syncytial Virus Fusion Proteins.
Yamaguchi-Sasaki T, Tokura S, Ogata Y, Kawaguchi T, Sugaya Y, Takahashi R, Iwakiri K, Abe-Kumasaka T, Yoshida I, Arikawa K, Sugiyama H, Kanuma K.
ACS Med Chem Lett (2020) 11 : 1145 -1151
PubMed 32550994 · DOI

Activity Statistics

Type Count Avg pChEMBL Best pChEMBL
EC50 1 10.00 10.00

Compounds Tested

Compound Name Phase Activities Best pChEMBL
CHEMBL3410450 PRESATOVIR 2.0 1 10.00

Activity Data

Compound Name Type Rel. Value Units pChEMBL
CHEMBL3410450 PRESATOVIR EC50 = 0.1 nM 10.00